Acumen Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 179.00 K

Acumen Pharmaceuticals, Inc. Depreciation And Amortization is USD 179.00 K for the Trailing 12 Months (TTM) ending March 31, 2025, a 1.70% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Acumen Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 176.00 K, a -4.35% change year over year.
  • Acumen Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 184.00 K, a 348.78% change year over year.
  • Acumen Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 41.00 K.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased